Everstone Capital

Everstone Capital And IFC Deepen Alliance with $60 Million in New Investment

Mumbai, 11th November 2025: Everstone Capital announced the signing of a new investment with the International Finance Corporation (IFC), strengthening its long-standing partnership. The investment underscores IFC’s continued confidence in the firm’s investment strategy and track record of scaling high-quality businesses across India and Southeast Asia.

IFC has committed US$ 60 million to Everstone Capital Partners V (Fund V), the private equity business of Everstone Group. The Fund will invest in mid-market companies across healthcare, technology, consumer goods, and financial services in India and Southeast Asia.

This follows IFC’s investments in Everstone’s funds III and IV, at $50 million each, as well as a $10 million co-investment alongside Everstone in Wingify, global Saas company. This strategic alliance has actively been instrumental in spurring innovation, establishing sustainability benchmarks, and generating tangible economic growth and job creation.

Commenting on the partnership, Sameer Sain, Co-founder and CEO, Everstone Group, said: “Our long-standing association with IFC reflects a shared commitment to combining financial discipline with impact. From supporting our private equity platforms to investing in sustainable infrastructure, IFC has consistently engaged as both a capital provider and a strategic partner. Together, we are building businesses that not only generate strong returns but also advance innovation, inclusion, quality job creation, and energy transition across emerging markets.”

Farid Fezoua, IFC Global Director for Disruptive Technologies, Services and Funds, said: “Mid-market companies are central to IFC’s strategy to advance job creation, economic resilience, and sustainable growth in India and Southeast Asia. Our partnership with Everstone is grounded in a shared mission to mobilise long-term private capital and drive innovation across priority sectors. By investing in Fund V, we aim to deliver lasting impact for business and communities across the region.”

Beyond capital, IFC has supported Everstone Capital in strengthening ESG standards and adopting IFC’s Performance Standards, reinforcing its ability to deliver sustainable value creation with rigorous risk management and impact measurement.

About Everstone Capital:

Everstone Capital, the private equity arm of the Everstone Group, is a Singapore-headquartered investment firm with $3.5 billion in assets under management and a presence across seven global offices. We focus on control-oriented, mid-market investments across high-growth sectors including Technology Services, Healthcare & Pharma, Consumer, Financial Services, and Industrials. Our platform-building approach combines operational expertise with strategic capital to unlock sustainable value and drive long-term growth.

With a team of ~100 experienced professionals, we bring deep domain knowledge, local insight, and an on-ground execution edge to every partnership. Our active ownership model and disciplined execution enable us to scale businesses, accelerate transformation, and consistently deliver strong risk-adjusted returns for our investors.

Website: https://everstonecapital.com/
LinkedIn: https://www.linkedin.com/company/everstonecapital/
For media enquiries, please write to: corpcomm@everstonegroup.com

For any enquiries, please contact

Naheed Contractor
ncontractor@everstonegroup.com
93245 41187

Shubhangi Chaturvedi
schaturvedi@eversourcecapital.com
96198 21154

Everstone Capital Acquires Majority Stake in Wingify, Strengthens its Tech Investment Portfolio

Mumbai/New Delhi, 24 January 2025: Singapore-based private equity firm Everstone Capital, acquires a majority stake in Wingify, a leading global provider of marketing technology SaaS product, VWO. The partnership includes a significant investment aimed at accelerating VWO’s product innovation and international growth. This highlights Everstone’s focus on supporting two key technology sectors: SaaS and marketing technology across India and Southeast Asia. VWO, with its established global goto-market capabilities, strong profitability, and technological leadership, presents an ideal partnership opportunity.

“Wingify is among a selectset of highly profitable,software companies emerging out of India that have carved a leading position globally. It is our second significant investment in the marketing technology space in the past 18 months. We congratulate the founders, Paras and Sparsh, on their journey and look forward to working with Sparsh and his team in Wingify’s next phase of growth.” said Sandeep Singh, Managing Director, Everstone Capital.

Co-founder & CEO, Sparsh Gupta and the leadership team will continue to hold a substantial equity stake in Wingify, retaining a majority of theirshareholding to collaborate with Everstone in driving the company’s next phase of growth. “We are confident that our partnership with Everstone will enable us to accelerate our expansion plans and further strengthen our global footprint. This paves the way for us to scale new heights in innovation and market reach.” said Sparsh.

Paras Chopra, Founder of Wingify, will continue to be a shareholder and remain on the board of the company. “I am confident that Sparsh and the Everstone team possessthe expertise and vision to lead the business through its next phase of success. I look forward to remaining involved as a shareholder and board member, providing guidance and support to ensure the company’s continued achievements.” said Paras.

Thisinvestment marks one of the most prominentsoftware buyoutsin India, underscoring Everstone’s confidence in the country’s thriving technology sector. Wingify is among a select few, India-bred SaaS companies that have achieved reasonable scale, with over $50M in ARR, attractive margins, and high profitability. The firm has a considerable global market presence, with the US and Europe accounting for ~90% of revenue.

“The technology sector in general, and the software space in particular, are key components of our private equity investment strategy. Wingify adds to the formidable technology franchise at Everstone Capital which has spanned investments in multiple sub sectors including tech enabled business services (Omega, Everise, MediaMint), digital engineering (Apexon, C Prime) and software (Acqueon).” said Avnish Mehra, Vice Chairman, head of private equity at Everstone Capital.

About Everstone Capital: Everstone Capital isthe Private Equity business of the Everstone Group, a global firm with assets under management exceeding USD 8 billion. Everstone Capital is committed to driving economic growth and creating sustainable value in India and Southeast Asia, with a mission to build great businesses with extraordinary people. The firm focuses on mid-market, control growth, and cross-border opportunities spanning Technology, Healthcare, Financial Services, and Industrials.

Website: https://everstonecapital.com/

About Wingify: Wingify is one of the major India-origin SaaS companies that has achieved remarkable scale and profitability. Its flagship product, VWO, serves over 3,000+ global brands, helping them optimize digital experiences and drive business growth. The company boasts an Annual Recurring Revenue (ARR) exceeding $50 million, industry-leading margins, and a significant global presence, with approximately 90% of its revenue generated from the US and Europe.

Website: https://wingify.com/
Media contact: Shubhangi Chaturvedi
9619821154 / corpcomm@everstonegroup.com

Private Equity at Goldman Sachs Alternatives and Everstone Capital sell co-control stake in Omega Healthcare

New York, Toronto – Private Equity at Goldman Sachs Alternatives (“Goldman Sachs”) and Everstone Capital (“Everstone”) have signed an agreement to sell a co-control stake in Omega Healthcare (“Omega”) to Ontario Teachers’ Pension Plan (“Ontario Teachers’”). Omega is a leading US-headquartered provider of revenue cycle management and clinical services to US healthcare organizations.

Omega works with healthcare customers to empower them to deliver exceptional care while enhancing financial performance. The firm helps its clients increase revenues, decrease costs, and improve the overall patient experience through their comprehensive portfolio of technology-enabled and clinically led solutions. Founded in 2003, Omega has approximately 35,000 employees across 14 delivery centers in the United States, India, Colombia, and the Philippines.

Omega has grown rapidly since 2019 with key value creation initiatives launched during this period under Goldman Sachs and Everstone’s ownership, enhancing Omega’s market position and financial profile. These initiatives include significant technology investment that has yielded benefits for customers through proprietary tools, automation, and in-house expertise. Omega has scaled global delivery capabilities and transformed the organization into a full-suite revenue cycle management provider. During this period, Omega also completed four acquisitions to enter new market segments such as clinical and data services and to add new delivery capabilities in the US and Colombia.

Harsh Nanda, Managing Director and Head of Technology Private Equity within Goldman Sachs Alternatives, commented: “It has been a very collaborative partnership with Everstone and a privilege to work with the Omega team, witnessing up-close the team’s drive and dedication to deliver outstanding outcomes for their customers.  Ontario Teachers’ decision to join us as an investment partner is a testament to Omega management team’s vision and exceptionality.”

“We are delighted to announce the successful sale of our co-control stake in Omega Healthcare,” said Avnish Mehra, Vice Chairman and Head of Private Equity at Everstone Capital. “During our ownership period, Omega witnessed a remarkable transformation, solidifying its strong position in the healthcare services industry. This growth is a testament to the remarkable management team and the robust business model that the team helped cultivate. We’re proud of the value created and are confident that Omega is well-positioned for continued success under the new partnership.”

“The last five years have been an incredible journey in partnership with Goldman Sachs and Everstone. The collaborative partnership with the investors has been instrumental in our efforts to accelerate Omega’s growth,” said Anurag Mehta,  Co-Founder and CEO of Omega. “We are thrilled to welcome Ontario Teachers’ into the Omega family and value the renewed commitment from Goldman Sachs and Everstone. This partnership reaffirms our commitment to leverage our domain expertise and our unique solutions to empower our clients.”

Advisors: Goldman Sachs & Co. LLC and TripleTree acted as co-lead financial advisors to Omega, and Weil, Gotshal & Manges served as legal counsel to Omega.

 About Private Equity at Goldman Sachs Alternatives

Goldman Sachs (NYSE: GS) is one of the leading investors in alternatives globally, with over $500 billion in assets and more than 30 years of experience. The business invests in the full spectrum of alternatives including private equity, growth equity, private credit, real estate, infrastructure, sustainability, and hedge funds. Clients access these solutions through direct strategies, customized partnerships, and open-architecture programs.

The business is driven by a focus on partnership and shared success with its clients, seeking to deliver long-term investment performance drawing on its global network and deep expertise across industries and markets.

The alternative investments platform is part of Goldman Sachs Asset Management, which delivers investment and advisory services across public and private markets for the world’s leading institutions, financial advisors and individuals. Goldman Sachs has more than $3.1 trillion in assets under supervision globally as of September 30, 2024.

Established in 1986, Private Equity at Goldman Sachs Alternatives has invested over $75 billion since inception. The business combines a global network of relationships, unique insight across markets, industries and regions, and the worldwide resources of Goldman Sachs to build businesses and accelerate value creation across its portfolios.

About Everstone Capital

Everstone Capital is the private equity business of the Everstone Group, a global firm with assets under management exceeding USD 8 billion. The firm is committed to driving economic growth and creating sustainable value in India and Southeast Asia. Its mission is to build great businesses with extraordinary people. Everstone Capital focuses on mid-market, control growth, and cross-border opportunities across Technology, Healthcare, Financial Services, and Industrials.

About Omega Healthcare

Founded in 2003, Omega Healthcare Management Services™ (Omega Healthcare) empowers healthcare organizations to deliver exceptional care while enhancing financial performance. We help clients increase revenues, decrease costs, and improve the overall patient-provider-payer experience through our comprehensive portfolio of technology-enabled and clinically led managed outsourcing solutions. Leveraging the Omega Digital Platform (ODP), customers benefit from the company’s expertise in artificial intelligence (AI), generative AI, robotic process automation (RPA), bots, machine learning (ML), and natural language processing (NLP), to drive greater efficiency and accuracy. Omega Healthcare has approximately 35,000 employees across 14 delivery centers in the United States, India, Colombia, and The Philippines. For more information, visit www.omegahms.com.

Contact Details
Omega Healthcare
Marykate Reese
Email: marykate.reese@omegahms.com

Everstone Capital
Shubhangi Chaturvedi
Email: corpcomm@everstonegroup.com

Goldman Sachs
Victoria Zarella
Email: victoria.zarella@gs.com

Integris Health Raises Primary Capital Ahead of Planned IPO

Mumbai, 9 January 2025: Integris Health, a leading medical devices company, has raised primary capital from a consortium of prominent investors, including Mukul Agarwal and India SME Fund. This funding will support the company’s expansion into multiple therapeutic areas such as in-vitro diagnostics and laboratory solutions through strategic acquisitions and in-house product development initiatives.

The investment marks a significant milestone for Integris Health, which aims to become one of India’s largest and most diversified medical devices players. In 2024, the company appointed Probir Das as CEO to lead its growth strategy. The company intends to list publicly by year-end 2025 and has commenced IPO preparations.

Avnish Mehra, Vice Chairman of Everstone Capital, said, “Integris Health’s growth trajectory reflects our commitment to building scalable healthcare platforms. This funding combined with the company’s proven product development capabilities, consistent organic growth and acquisition track record reinforces its position as a transformative med-tech devices business serving hospitals and laboratories globally.”

Gurmit Singh Chugh, Co-Founder and Chairman of Integris Health, added, “The Indian med-tech devices industry is experiencing an unprecedented growth phase akin to the transformative opportunities witnessed by the Indian pharmaceutical sector in the early 2000s. Integris Health is poised to spearhead this global evolution, leveraging its cutting-edge R&D, strategic partnerships, robust distribution capabilities, and the cost-efficiency of Indian manufacturing.”

Probir Das, CEO of Integris Health, commented, “The interest and support from prominent investors reflects the confidence in our vision to create India’s leading med-tech devices business. As we plan for our IPO, we remain committed to building Integris into a diversified business in this space. This market, particularly in developing economies is poised for significant growth due to low penetration levels, and Integris is well-positioned to capitalize on this opportunity.”

About Integris Health:

Integris Health, backed by Everstone Capital is an India-headquartered medical devices company with presence in interventional cardiology, cardiovascular and vascular surgery therapy areas. It is a fully integrated company with end-to-end presence in product development, manufacturing and sales and distribution with manufacturing facilities in Germany, Netherlands and India, and sales presence in over 50 markets. Over the years, the company has created strategic partnerships with leading hospitals, engineering institutes, global med-tech devices companies and renowned interventional cardiologists. Integris combines the best of German engineering, intellectual property and high-quality standards with India’s entrepreneurial culture and strong capabilities in manufacturing innovative products at affordable prices.

About Everstone Capital:

Everstone Capital is the Private Equity business of the Everstone Group, a global firm with assets under management exceeding USD 8 billion. Everstone Capital is committed to driving economic growth and creating sustainable value in India and Southeast Asia, with a mission to build great businesses with extraordinary people. The firm focuses on mid-market, control growth, and cross-border opportunities spanning Technology, Healthcare, Financial Services, and Industrials.

Integris Appoints veteran Sanjeev Kumar as Group CFO

Mumbai, January 2025: Integris, a globally diversified medical technology company, appoints Sanjeev Kumar as its Group Chief Financial Officer, effective Feb 3, 2025. Based in New Delhi, Sanjeev will report to the Group CEO, Probir Das and will play a key role in driving the company’s next phase of accelerated growth and innovation.

Integris, backed by Everstone Capital and its promoters Gurmit Chugh & Punita Arora, operates in 4 key segments within cardiovascular devices and in-vitro diagnostics across India, Southeast Asia, Europe, Middle East and Latin America.

Probir Das, Group CEO, Integris, said, “Sanjeev’s impressive track record in leading finance functions for large businesses, combined with his expertise in navigating successful IPOs in India, makes him an invaluable addition to our team. We look forward to his strategic guidance in driving Integris’ financial strategy and sustainable growth.”

“I am excited to join Integris and contribute to the company’s vision of delivering innovative medical technology-based solutions. I look forward to fostering a balance between growth orientation, operational efficiency, and strong compliance.”  Sanjeev added.

With over three decades of experience in finance, Sanjeev has held key leadership roles at Bharti Airtel Limited and InterGlobe Enterprises Limited. Most recently, he served as the Group Chief Financial Officer at Medanta – The Medicity, where he led India’s largest IPO in the hospital sector and significantly expanded profit margins. An alumnus of Shri Ram College of Commerce, University of Delhi, Sanjeev is also an ICAI-certified Chartered Accountant and a Company Secretary. He has recently completed Harvard’s Advanced Management Programme.

About Integris:
Integris is a diversified MedTech platform with four significant business segments: Clinical Diagnostics, Scientific Lab Solutions, Cardiovascular Devices, and Vascular Access Therapies. The platform provides a strong product development and manufacturing core coupled with an unparalleled access to customers across India, Southeast Asia, Europe, Latam and the Middle East, serving diverse sets of customers across multiple therapeutic areas within the treatment continuum.

About Everstone Capital: Everstone Capital is the Private Equity business of the Everstone Group, a global firm with assets under management of over $8Bn committed to driving economic growth and creating sustainable value in India and Southeast Asia with a mission to build great businesses with extraordinary people. Everstone Capital is focused on mid-market, control growth and crossborder opportunities across Technology, Healthcare, Financial Services, and Industrials.

Website: https://everstonecapital.com/

Media contact:
Shubhangi Chaturvedi
9619821154 / corpcomm@everstonegroup.com

Integris Appoints MedTech Veteran Probir Das as New CEO

Integris Healthcare, a global diversified medical technology (MedTech) company, announced the appointment of Probir Das as Chief Executive Officer. He will join effective November 2024 and will be based in New Delhi, India. With over three decades of global MedTech experience, Probir will lead the next phase of growth and innovation for the Company. Probir joins Integris from Terumo Asia Pacific, where he served as Chairman & Managing Director since 2019.

Avnish Mehra, Vice Chairman – Everstone Capital commented, “Probir’s exceptional track record of scaling businesses at Terumo both in India and in Southeast Asia, combined with his years of experience in India at Becton Dickenson and at Boston Scientific make him the ideal leader to take Integris to new heights.”

Gurmit Chugh, Co-Founder the cardiovascular business within Integris (along with Punita Sharma) said, “I have seen Probir scaling many businesses in the last 25 years with his deep understanding of MedTech markets. He is an inspiring leader who creates a culture of collaboration and accountability empowering teams to exceed their goals. He is highly regarded for his adaptability and commitment to sustainable growth.”

Probir Das commented, “Throughout my career, I have focused on driving innovation, establishing new therapies, and fostering rapid growth in the MedTech sector. Together with Integris’ talented team, I look forward to expanding our market presence, delivering cutting-edge medical technologies to patients worldwide, and ultimately transforming healthcare delivery on a global scale.”

About Integris:

Integris is a diversified MedTech platform with four key business segments: Cardiovascular Devices, Clinical Diagnostics, Scientific Lab Solutions, and Vascular Access Therapies. The platform provides a strong product development and manufacturing core, coupled with unparalleled access to customers across the world. The company has R&D expertise and manufacturing facilities set out of India, Germany and Netherlands with strong global compliance. Integris also has strong distribution and commercialization platforms in some key strategic markets for distributing unique and innovative technologies from other MedTech players. Integris is backed by Everstone Capital and promoters Gurmit Chugh & Punita Arora.

About Everstone Capital:

Everstone Capital is the Private Equity business of the Everstone Group, a global firm with assets under management of over USD 8 Bn committed to driving economic growth and creating sustainable value in India and Southeast Asia, with a mission to build great businesses with extraordinary people.  Everstone Capital is focused on mid-market, control growth and cross-border opportunities spanning Technology, Healthcare, Financial Services, and Industrials.